Summary
Type 1 (insulin-dependent) diabetic patients with clinical nephropathy have a more than ten-fold increase in mortality of cardiovascular diseases compared with diabetic patients without nephropathy. The risk factors for cardiovascular disease, plasma concentrations of lipoproteins and fibrinogen, were investigated in 74 long-term diabetic patients: 37 with normal urinary albumin excretion, 20 with incipient nephropathy and 17 with overt clinical nephropathy based on urinary albumin excretion. The groups were matched according to sex, age and diabetes duration. The concentration of plasma cholesterol, very low density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride and fibrinogen rose with increasing urinary albumin excretion. The plasma concentrations of these lipoproteins and fibrinogen were 11–14% higher in the patients with incipient nephropathy and 26–87% higher in the patients with overt clinical ne phropathy compared with the patients without nephropathy. The plasma concentration of high density lipoprotein cholesterol was unaffected by albuminuria. Patients with normal urinary albumin excretion and HbA1c>8.0% had significantly higher very low density lipoprotein- and lower high density lipoprotein cholesterol concentrations compared with patients with HbA1c<8.0%. Simple addition of the described risk factors can only account for a minor part of the greatly increased cardiovascular mortality in patients with diabetic nephropathy. An additional and possibly more decisive factor might be a change in the arterial wall, a change which promotes lipid accumulation and/or facilitates thrombus formation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Borch-Johnsen K, Kragh Andersen P, Deckert T (1985) The effect of proteinuria on relative mortality in Type I (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 6: 356–360
Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1: 17–19
Borch-Johnsen K, Kreiner S (1987) Proteinuria — a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294: 1651–1655
Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T (1987) Coronary disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Incidence and risk factors. Diabetologia 30: 144–148
Christiansen JS (1978) Cigarette smoking and prevalence of microangiopathy in juvenile onset insulin-dependent diabetes mellitus. Diabetes Care 1: 146–149
Parving H-H, Andersen AR, Smidt UM, Oxenbøll B, Edsberg B, Sandahl Christiansen J (1983) Diabetic nephropathy and arterial hypertension. Diabetologia 24: 10–12
Feldt-Rasmussen B, Borch-Johnsen K, Mathiesen ER (1985) Hypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension 7 [Suppl 2] 1118–1120
Valdorf-Hansen F (1967) Coagulability in diabetics. Acta Med Scand [Suppl] 476: 147–157
Keiding NR, Mann GV, Root HF, Lawry EY, Marble A (1952) Serum lipoproteins and cholesterol levels in normal subjects and in young patients with diabetes in relation to vascular complications. Diabetes 1 (6): 434–440
Eckel RH, McLean E, Albers JJ, Cheung MC, Bierman EL (1981) Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care 4: 447–453
Vannini P, Clavarella A, Flammini M, Bargossi AM, Forlani G, Borgnino LC, Orsoni G (1984) Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 7: 151–154
Feldt-Rasmussen B, Dinesen B, Deckert M (1985) Enzyme immuno assay — an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45: 539–544
Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in normal serum. J Clin Invest 34: 1345–1353
Jacobsen K (1955) Method for the determination of fibrinogen in plasma. Scand J Clin Lab Invest [Suppl.] 14: 14–16
Svendsen PAA, Christiansen JS, Søegaard U, Welinder BA, Nerup J (1980) Rapid change in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia 19: 130–136
Larsen K (1972) Creatinine assay by a reaction-kinetic principle. Clin Chem Acta 41: 209–217
Hanning I, Home PD, Alberti KGMM (1985) Measurements of free insulin concentrations: the influence of timing of extraction of insulin antibodies. Diabetologia 28: 831–835
Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebre P, Mathiesen ER, Feldt-Rasmussen B, Schmiitz A, Viberti GC (1985–1986) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9 (2): 85–95
Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF (1981) Hyperlipidaemia in untreateded nephrotic syndrome, increased production or decreased removal? Clin Chim Acta 117: 317–323
Ohta T, Matsuda I (1981) Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chem Acta 117: 133–143
Felts JM, Mayerle JA (1974) Urinary loss of plasma high density lipoprotein — a possible cause of hyperlipidaemia of the nephrotic syndrome. Circulation 50 [Suppl. 3]: 263
Stender S, Hjelms E (1987) In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest 47 [Suppl. 186]: 21–29
Renkin EM (1977) Multiple pathways of capillary permeability. Circ Res 4: 735–743
Pietri A, Dunn FL, Raskin P (1980) The effect on improved diabetic control on plasma lipid and lipoprotein levels. A comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes 29: 1001–1005
Nikkilä EA (1981) High density lipoproteins in diabetes. Diabetes 30 [Suppl. 2]: 82–87
Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA 251: 351–374
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttonen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317: 1237–1245
Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG (1986) Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study. Lancet II: 533–537
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jensen, T., Stender, S. & Deckert, T. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31, 142–145 (1988). https://doi.org/10.1007/BF00276846
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00276846